|
TMEM181 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.850430E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.230200E-01 |
| Normal-vs-Stage2 |
1.716440E-01 |
| Normal-vs-Stage3 |
1.072630E-01 |
| Normal-vs-Stage4 |
1.146640E-01 |
| Stage1-vs-Stage2 |
2.741600E-01 |
| Stage1-vs-Stage3 |
1.610820E-01 |
| Stage1-vs-Stage4 |
1.849180E-01 |
| Stage2-vs-Stage3 |
9.270400E-01 |
| Stage2-vs-Stage4 |
9.705400E-01 |
| Stage3-vs-Stage4 |
8.767200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.504600E-01 |
| Normal-vs-AfricanAmerican |
1.906240E-02 |
| Normal-vs-Asian |
9.013200E-01 |
| Caucasian-vs-AfricanAmerican |
5.519500E-02 |
| Caucasian-vs-Asian |
7.254000E-01 |
| AfricanAmerican-vs-Asian |
2.362000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.037600E-01 |
| Normal-vs-Female |
1.918990E-01 |
| Male-vs-Female |
8.940400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.104400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.189400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.134030E-01 |
| Normal-vs-Age(81-100Yrs) |
1.270370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.640400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.764000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.485200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.668040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.743550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.407800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.585600E-01 |
| Normal-vs-Grade 2 |
6.504200E-01 |
| Normal-vs-Grade 3 |
3.747900E-02 |
| Normal-vs-Grade 4 |
9.819900E-02 |
| Grade 1-vs-Grade 2 |
1.567370E-01 |
| Grade 1-vs-Grade 3 |
4.963500E-03 |
| Grade 1-vs-Grade 4 |
2.965500E-02 |
| Grade 2-vs-Grade 3 |
3.618100E-03 |
| Grade 2-vs-Grade 4 |
8.078100E-02 |
| Grade 3-vs-Grade 4 |
8.287600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.951000E-01 |
| Normal-vs-ccB subtype |
3.351200E-01 |
| ccA subtype-vs-ccB subtype |
6.271600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.702200E-01 |
| Normal-vs-N1 |
3.357800E-01 |
| N0-vs-N1 |
4.724600E-01 |
|
|
